IPP Bureau
Need for national-level awareness about organ transplant surgeries & organ donation in India
By IPP Bureau - July 05, 2022
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Novavax aims COVID vaccine on Omicron in Q4
By IPP Bureau - July 05, 2022
The vaccine is under FDA review
Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries
By IPP Bureau - July 05, 2022
Medicines, including insulin, to be available in 40 lower-income countries
Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
By IPP Bureau - July 05, 2022
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
OliX Pharmaceuticals submits application to U.S. FDA to evaluate safety and tolerability of OLX10212
By IPP Bureau - July 04, 2022
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Clinical study of PD-L1 antibody ASC22 for cure of HIV completes first patient dosing
By IPP Bureau - July 04, 2022
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
USFDA conducts inspection at Glenmark's Aurangabad manufacturing facility
By IPP Bureau - July 04, 2022
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
.jpg "Microsize launched as Independent pharma services company"){kind=logo}
Microsize launched as Independent pharma services company
By IPP Bureau - July 04, 2022
Meets the growing need for US-based API solubility and bioavailability enhancement services
Pfizer submits new drug application to the U.S. FDA for Paxlovid
By IPP Bureau - July 03, 2022
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
Pfizer to achieve net-zero standard by 2040
By IPP Bureau - July 03, 2022
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
By IPP Bureau - July 03, 2022
Govt committed to supporting pharma companies with industry-friendly policies
Maria Soler Nunez appointed Head, Group Operations of Lonza
By IPP Bureau - July 02, 2022
Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Lonza to invest 500 mn in commercial drug product fill & finish facility
By IPP Bureau - July 02, 2022
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
UK Parliament honours All India Institute of Ayurveda’s Director Dr Tanuja Nesari with Ayurveda Ratna Award
By IPP Bureau - July 02, 2022
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
By IPP Bureau - July 02, 2022
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
